Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke Model
- 12 December 2019
- journal article
- research article
- Published by Elsevier BV in Neurotherapeutics
- Vol. 17 (2), 627-634
- https://doi.org/10.1007/s13311-019-00809-1
Abstract
No abstract availableKeywords
Funding Information
- Multiple Sclerosis Society of Western Australia (N/A)
This publication has 55 references indexed in Scilit:
- Nonhuman Primate Models of Stroke for Translational Neuroprotection ResearchNeurotherapeutics, 2012
- Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brainNature, 2012
- Neuroprotection by Freezing Ischemic Penumbra Evolution Without Cerebral Blood Flow Augmentation With a Postsynaptic Density-95 Protein InhibitorStroke, 2011
- Specific Targeting of Pro-Death NMDA Receptor Signals with Differing Reliance on the NR2B PDZ LigandJournal of Neuroscience, 2008
- Effectiveness of PSD95 Inhibitors in Permanent and Transient Focal Ischemia in the RatStroke, 2008
- Two Tales: Hemorrhagic Transformation but Not Parenchymal Hemorrhage After Thrombolysis Is Related to Severity and Duration of IschemiaStroke, 2007
- User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliabilityNeuroImage, 2006
- L-arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in ratsThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Proline- and Arginine-Rich Peptides Constitute a Novel Class of Allosteric Inhibitors of Proteasome ActivityBiochemistry, 2003
- Effect of Polycation Peptides on Mitochondrial Permeability TransitionBiochemical and Biophysical Research Communications, 1995